tiprankstipranks
Trending News
More News >
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719)
:0719
Hong Kong Market

Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Financial Statements

Compare
2 Followers

Shandong Xinhua Pharmaceutical Company Limited Class H Financial Overview

Shandong Xinhua Pharmaceutical Company Limited Class H's market cap is currently HK$10.24B. The company's EPS TTM is HK$0.051; its P/E ratio is 11.58; and it has a dividend yield of 4.47%. Shandong Xinhua Pharmaceutical Company Limited Class H is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is HK$0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 8.47B¥ 8.10B¥ 7.50B¥ 6.56B¥ 6.01B
Gross Profit¥ 2.04B¥ 2.32B¥ 2.04B¥ 1.77B¥ 1.81B
Operating Income¥ 534.37M¥ 534.58M¥ 476.71M¥ 425.59M¥ 422.49M
EBITDA¥ 1.11B¥ 1.09B¥ 1.01B¥ 908.67M¥ 856.79M
Net Income¥ 470.02M¥ 496.51M¥ 411.06M¥ 348.55M¥ 324.86M
Balance Sheet
Cash & Short-Term Investments¥ 1.25B¥ 918.33M¥ 1.16B¥ 744.66M¥ 855.77M
Total Assets¥ 9.02B¥ 8.29B¥ 8.27B¥ 7.33B¥ 7.09B
Total Debt¥ 1.35B¥ 1.08B¥ 1.38B¥ 1.04B¥ 1.09B
Net Debt¥ 107.78M¥ 166.60M¥ 225.11M¥ 299.09M¥ 231.77M
Total Liabilities¥ 3.80B¥ 3.51B¥ 3.92B¥ 3.68B¥ 3.70B
Stockholders' Equity¥ 4.99B¥ 4.55B¥ 4.13B¥ 3.47B¥ 3.22B
Cash Flow
Free Cash Flow¥ 155.19M-¥ 513.48M¥ 9.89M¥ 140.00M
Operating Cash Flow¥ 367.61M¥ 265.28M¥ 758.24M¥ 259.12M¥ 420.19M
Investing Cash Flow¥ -212.21M----
Financing Cash Flow¥ 184.78M¥ -196.11M--¥ 35.04M
Currency in CNY

Shandong Xinhua Pharmaceutical Company Limited Class H Earnings and Revenue History

Shandong Xinhua Pharmaceutical Company Limited Class H Debt to Assets

Shandong Xinhua Pharmaceutical Company Limited Class H Cash Flow

Shandong Xinhua Pharmaceutical Company Limited Class H Forecast EPS vs Actual EPS